Tlr779 mice — in which the Tlr7 TIR domain was replaced with the Tlr9 TIR domain — showed disease amelioration when compared with WT Tlr7 counterparts in the lupus-prone MRL/lpr Tlr9–/– background. This evidence concerns the gene TLR9 and systemic lupus erythematosus.